Actavis

Actavis is a top pharmaceutical company based in New Jersey, USA

Actavis is a top pharmaceutical company based in New Jersey, USA.Actavis was founded as Watson Pharmaceuticals Inc. in 1984.The change of the trading name followed the company's acquisition of the global Generics Pharmaceutical Company Actavis Group in October 2012.

Actavis is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.

Report: Partnering Deals and Alliances with Actavis (formerly Watson Pharmaceuticals)

Actavis is a top pharmaceutical company based in New Jersey, USA.

Actavis was founded as Watson Pharmaceuticals Inc. in 1984.

The change of the trading name followed the company's acquisition of the global Generics Pharmaceutical Company Actavis Group in October 2012.

Actavis is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.

Actavis is the world’s third-largest generic pharmaceutical company, with more than 750 molecules in 1,700 dosage combinations marketed globally through operations in more than 60 countries.

The company carries out its operation through three major global businesses; all focused on advancing innovations that provide better options and outcomes, enabling healthier lives.

  • Actavis Speciality Brands – The division is focused on leadership in Urology and Women’s Health.  The speciality brand markets more than 40 pharmaceuticals products in the U.S.
  • Actavis Pharma – The Company markets a broad product line consisting of multiple dosage forms a strong position in generic oncology injectables and an expanded OTC presence.
  • Actavis’ Anda, Inc. – The Company’s distribution business primarily distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from more than 200 suppliers to more than 62,000 locations, including independent pharmacies, alternate care providers, pharmacy chains and physicians' offices.

Actavis has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Actavis has a long history of partnering, building numerous collaborative partnershipsmore

Actavis announced over 38 partnering / licensing deals since 2005. Analysis of the partnering deals shows a strong emphasis on partnerships in central nervous systemcardiovascular followed by dermatology and gastro intestinal more

Actavis has also announced over 19 M&A deals since 2005, with the lead deals being the acquisition of Watson Pharmaceuticals, Warner-Chilcott and Lotus Pharmaceuticals more

Report: Partnering Deals and Alliances with Actavis (formerly Watson Pharmaceuticals)

Examples of recent partnering and licensing deals announced by Actavis can be viewed in Current Partnering's Partnering Deals and Alliances with Actavis (formerly Watson Pharmaceuticals) partnering activity review article.

Examples of recent M&A deals announced by Actavis can be viewed in Current Partnering's Partnering Deals and Alliances with Actavis (formerly Watson Pharmaceuticals) activity review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Actavis (formerly Watson Pharmaceuticals)

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Actavis (formerly Watson Pharmaceuticals)

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Actavis

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Actavis company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email